Xiamen Amoytop Biotech Co., Ltd.
Clinical trials sponsored by Xiamen Amoytop Biotech Co., Ltd., explained in plain language.
-
Early safety check for drug aimed at preventing preeclampsia
Knowledge-focused CompletedThis study tested a new drug, telpegfilgrastim, in 18 non-pregnant women to see if it is safe and how the body processes it. Half of the participants had a history of preeclampsia, a dangerous pregnancy condition. The goal was to gather safety data and measure drug levels in the …
Phase: PHASE1 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 17, 2026 05:10 UTC
-
Healthy volunteers test new drug for fatty liver disease
Knowledge-focused CompletedThis early-stage study tested the safety of a new drug called ACT500 in 72 healthy Chinese adults. Participants received either the drug or a placebo, and researchers monitored for side effects and how the drug moves through the body. The goal was not to treat disease but to gath…
Phase: PHASE1 • Sponsor: Xiamen Amoytop Biotech Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 15, 2026 18:55 UTC